Search Results
Jun 03, 2026, 12:05 ET Populus Financial Group Supports Youth Financial Education with $15,000 Donation to Junior Achievement
Populus volunteers teach the JA in a Day program twice a year to students in kindergarten through 5th grade at J. O. Davis Elementary School. Through a series of interactive lessons and activities, students explore key concepts such as earning, saving, spending,
More news about: Populus Financial Group, Inc.
Jun 03, 2026, 12:00 ET The Paley Center for Media to Present a Timely Conversation on the Future of Global Storytelling at SNF Nostos 2026 in Athens, Greece
perspective on the future of entertainment and the powerful ways storytelling continues to connect audiences across cultures and borders," said Maureen J. Reidy, President & CEO of The Paley Center for Media. "We are especially honored to take part in SNF Nostos 2026 during this milestone anniversary
More news about: The Paley Center for Media
Jun 03, 2026, 10:21 ET KOMISJA EUROPEJSA ZATWIERDZA PREPARAT IMDYLLTRA® FIRMY AMGEN DO LECZENIA DROBNOKOMÓRKOWEGO RAKA PŁUCA W POSTACI ROZSIANEJ
cancer after platinum-based chemotherapy (Tarlatamab w drobnokomórkowym raku płuca po chemioterapii opartej na związkach platyny). N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg and 10 mg powder for concentrate and solution for infusion: Summary of product
More news about: Amgen
Jun 03, 2026, 10:11 ET /C O R R E C T I O N -- Community Servings/
promise."What the Findings Mean for Medicaid and Healthcare PolicyThe study, led by researchers from the Food is Medicine Institute at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and UMass Chan Medical School, analyzed Medicaid claims data for 1,866
More news about: Community Servings
Jun 03, 2026, 10:00 ET HkeyBio New Platform Launch: AIH, PBC, and IgAN Model Matrix Empowers "One Drug, Multiple Screens" in Autoimmune New Drug R&D
(EASL). EASL Clinical Practice Guidelines: Autoimmune hepatitis.Journal of Hepatology. 2015;63(4):971–1004.Lindor KD, Bowlus CL, Boyer J, et al. Primary Biliary Cholangitis: 2018 Practice Guidance.Hepatology. 2019;69(1):394–419.KDIGO Glomerular Diseases Work Group. KDIGO
More news about: HKeyBio
Jun 03, 2026, 09:43 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
ЛИТЕРАТУРЫMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 мг и 10 мг порошок для концентрата и раствор для инфузий: Summary of product characteristics.
More news about: Amgen
Jun 03, 2026, 09:30 ET SweetNight Launches CoolNest® Pro, an Upgraded Memory Foam Mattress Engineered for Hot Sleepers
manage temperature across four stages of the night:The surface delivers immediate cooling through an Ice Silk cover with a Qmax rating of 0.23 J/(cm²•s) — roughly 35% cooler to the touch than standard mattress fabrics. Below the cover, a layer of SweetNight's proprietary PCMflux® foam, infused with
More news about: SweetNight
Jun 03, 2026, 09:27 ET LA CE APRUEBA IMDYLLTRA® DE AMGEN PARA EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO AVANZADO
(inversores) REFERENCIASMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg and 10 mg powder for concentrate and solution for infusion: Summary of product
More news about: Amgen
Jun 03, 2026, 09:00 ET PBI-Gordon Companies Names Kent Luther Vice President of Sales and Commercial Operations for Pegasus Laboratories
announced that Kent Luther has joined Pegasus Laboratories as Vice President of Sales and Commercial Operations. In this role, Luther reports to Joyce J. Lee, Senior Vice President and General Manager of Pegasus, and serves as a member of the Pegasus leadership team. Luther's appointment is the
More news about: PBI-Gordon Companies, Inc.
Jun 03, 2026, 09:00 ET MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Certified Misleading Statements: Levi & Korsinsky
Executive Officer, who directed earnings call communications and provided book-to-bill projections to analysts throughout the Class PeriodJesse J. Geiger, President, who delivered quarterly revenue and backlog figures to the investing publicKevin M. Brady, Chief Financial Officer
More news about: Levi & Korsinsky, LLP
Jun 03, 2026, 09:00 ET AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
805-447-1746 (investors)ReferencesStone J, et al. Oral Presentation at European Alliance of Associations for Rheumatology (EULAR) 2026 Congress. June 3-6, 2026: Abstract #OP052.Stone J, et al. Poster Presentation at European Alliance of Associations for Rheumatology
More news about: Amgen
Jun 03, 2026, 08:37 ET Mark Tabakin and 6-Attorney Team Join Scarinci Hollenbeck, Advancing Statewide Vision
Dorian J. Smith as a Senior Associate in the Labor & Employment and Public Law Groups in Little Falls. Dorian joins the firm from the Office of Governor
More news about: Scarinci Hollenbeck, LLC
Jun 03, 2026, 08:33 ET Seven Regan Zambri Long Attorneys Named to 2026 Washington, DC Super Lawyers List
Founding Partner Patrick M. ReganFounding Partner Salvatore J. ZambriFounding Partner Victor E. LongPartner Paul J. CornoniPartner Jacqueline T. ColcloughPartner Christopher J. ReganAttorney Emily C. Lagan was named to the Rising Stars list.This
More news about: Regan Zambri Long PLLC
Jun 03, 2026, 08:30 ET FLAGSTAR BANK, N.A. TO PARTICIPATE AT THE MORGAN STANLEY U.S. FINANCIALS CONFERENCE
Midwest, along with a significant presence in fast-growing markets in Florida and the West Coast.Investor Contact:Salvatore J. DiMartino(516) 683-4286
More news about: Flagstar Bank, N.A.
Jun 03, 2026, 08:00 ET Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
2026. Specification data from BACT/ALERT® VIRTUO® 510(k) Substantial Equivalence Determination Decision Summary (K161816); page 5, Table J3. Waters Press Release, April 15, 2026:
More news about: Waters Corporation
Jun 03, 2026, 08:00 ET Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
2026. Specification data from BACT/ALERT® VIRTUO® 510(k) Substantial Equivalence Determination Decision Summary (K161816); page 5, Table J3. Waters Press Release, April 15, 2026:
More news about: Waters Corporation
Jun 03, 2026, 07:47 ET A World First: A Major Innovation in Blood Transfusion
investment.1 Sperry JL, et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315-326CAUTION:The FrontlineODP™ Spray Dried Plasma System has not received FDA or EU approval for any indication.
More news about: Velico Medical, Inc
Jun 03, 2026, 07:41 ET A World First: A Major Innovation in Blood Transfusion
investment.1 Sperry JL, et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315-326CAUTION:The FrontlineODP™ Spray Dried Plasma System has not received FDA or EU approval for any indication.
More news about: Velico Medical, Inc
Jun 03, 2026, 07:25 ET Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Receptor Inhibitors and Offers Flexible, Well-Tolerated Dosing in Prostate Cancer Models
1 Candelieri-Surette D, Lee J, Lynch JA, et al. Epidemiology of Metastatic Castration-Resistant Prostate Cancer in Veterans Nationwide. J Natl Compr Canc Netw. 2025;23(8):307–313. doi:10.6004/jnccn.2025.7032.The
More news about: Actinium Pharmaceuticals, Inc.
Jun 03, 2026, 07:00 ET Ascidian and Lilly Enter Global Research Collaboration to Develop RNA Exon Editors for Devastating Kidney Diseases
Gharavi AG; NKF Genetic Testing Working Group. Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group. Am J Kidney Dis. 2024 Dec;84(6):751-766.
More news about: Ascidian Therapeutics
Jun 03, 2026, 04:00 ET Premiere auf Kickstarter: SEA-GULL präsentiert limitierten Rattrapante-Chronographen mit Meteoritenzifferblatt
https://www.kickstarter.com/projects/seagullwatch/sea-gull-meteorite-rattrapante-chronograph-global-launch?ref=b5p84jAuslieferungen beginnen voraussichtlich im Juli 2026, Backer werden in Reihenfolge ihrer
More news about: SEA-GULL Watch
Jun 03, 2026, 04:00 ET Une première sur Kickstarter : SEA-GULL dévoile un chronographe rattrapante à cadran météorite en édition limitée
https://www.kickstarter.com/projects/seagullwatch/sea-gull-meteorite-rattrapante-chronograph-global-launch?ref=b5p84jLes livraisons devraient commencer en juillet 2026, les contributeurs seront informés
More news about: SEA-GULL Watch
Jun 03, 2026, 04:00 ET Un estreno en Kickstarter: SEA-GULL presenta el cronógrafo rattrapante con esfera de meteorito en edición limitada
https://www.kickstarter.com/projects/seagullwatch/sea-gull-meteorite-rattrapante-chronograph-global-launch?ref=b5p84jLas entregas comenzarán en julio de 2026.Acerca de SEA-GULL Watch GroupFundado
More news about: SEA-GULL Watch
Jun 03, 2026, 03:02 ET Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1 Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 03, 2026, 02:58 ET FS KKR Capital Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FSK
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1 Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP